Loading...
Loading...
FBRX| Name | Value |
|---|---|
| Revenues | 0.0M |
| Cost of Revenue | 0.0M |
| Gross Profit | -0.0M |
| Operating Expense | 12.8M |
| Operating I/L | -12.8M |
| Other Income/Expense | 0.3M |
| Interest Income | 0.0M |
| Pretax | -12.5M |
| Income Tax Expense | 0.0M |
| Net Income/Loss | -12.5M |
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing the FB-102 program to address autoimmune diseases like vitiligo and alopecia areata. By advancing innovative treatments, the company aims to generate revenue through the successful development and commercialization of therapies for these conditions.
